Huang H - Search Results

1

MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16.

Qian D, Chen K, Deng H, Rao H, Huang H, Liao Y, Sun X, Lu S, Yuan Z, Xie D, Cai Q. Qian D, et al. Among authors: huang h. Clin Cancer Res. 2015 Nov 1;21(21):4881-91. doi: 10.1158/1078-0432.CCR-14-2947. Epub 2015 Jun 22. Clin Cancer Res. 2015. PMID: 26100275

2

[Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma].

Li YH, Jiang WQ, Huang HQ, Zhang L, Liu DG, Xu RH, Zhou ZM, Sun XF, Lin TY, Xu GC, He YJ, Guang ZZ. Li YH, et al. Ai Zheng. 2002 Aug;21(8):900-2. Ai Zheng. 2002. PMID: 12478903 Clinical Trial. Chinese.

3

[Clinical results of 295 patients with Hodgkin's disease treated by chemotherapy-predominant comprehensive modality].

Huang HQ, Jiang WQ, Wang W, Xu GC, Zhang L, He YJ, Sun XF, Zhou ZM, Liu DG, Xu RH, Lin TY, Teng XY, Liu MZ, Su YS, Li YH, Lin XB, Guan ZZ. Huang HQ, et al. Ai Zheng. 2002 Dec;21(12):1345-9. Ai Zheng. 2002. PMID: 12520745 Chinese.

4

[Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].

Huang HQ, Jiang WQ, Wang W, Zhou ZM, Xia ZJ, Lin XB, Li YH, Xu RH, Zhang L, Xu GC, Sun XF, Liu DG, He YJ, Guan ZZ. Huang HQ, et al. Ai Zheng. 2003 Apr;22(4):389-92. Ai Zheng. 2003. PMID: 12703995 Clinical Trial. Chinese.

5

[Curative effect on aggressive B cell non-Hodgkin's lymphoma and relevant influencing factors of its prognosis, a study of 203 cases].

Xu RH, Jiang WQ, Li YH, Lin TY, Huang HQ, Xia ZJ, Sun XF, He YJ, Guan ZZ. Xu RH, et al. Zhonghua Yi Xue Za Zhi. 2003 Feb 10;83(3):191-4. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12812658 Chinese.

6

[Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases].

Huang HQ, Jiang WQ, Peng YL, Xia ZJ, Li YH, Li XB, Lin TY, Sun XF, Guan ZZ. Huang HQ, et al. Ai Zheng. 2004 Apr;23(4):448-51. Ai Zheng. 2004. PMID: 15087037 Chinese.

7

[Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].

Sun XF, Su YS, Liu DG, Jiang WQ, He YJ, Lin TY, Huang HQ, Zhang L, Xia ZJ, Li YH, Zhou ZM, Chen XQ, Xia Y, Zhen ZJ, Guan ZZ. Sun XF, et al. Ai Zheng. 2004 Aug;23(8):933-8. Ai Zheng. 2004. PMID: 15301718 Chinese.

8

[Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].

Huang HQ, Peng YL, Lin XB, Sun XF, Lin TY, Xia ZJ, Li YH, Cai QQ, He YJ, Jiang WQ, Guan ZZ. Huang HQ, et al. Ai Zheng. 2004 Nov;23(11 Suppl):1443-7. Ai Zheng. 2004. PMID: 15566653 Chinese.

9

[Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].

Zhang HY, Lin TY, Jiang WQ, Zhang L, Huang HQ, Xia ZJ, Sun XF, He YJ, Guan ZZ. Zhang HY, et al. Ai Zheng. 2004 Dec;23(12):1681-6. Ai Zheng. 2004. PMID: 15601560 Chinese.

10

[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].

Sun XF, Jiang WQ, Liu DG, Xia ZJ, Huang HQ, Zhang L, Li YH, Zhou ZM, Zhen ZJ, Xia Y, He YJ, Guan ZZ. Sun XF, et al. Ai Zheng. 2004 Dec;23(12):1687-91. Ai Zheng. 2004. PMID: 15601561 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,859 results

Search Page

Filters